Filing Details
- Accession Number:
- 0000950170-23-072730
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-12-22 17:01:07
- Reporting Period:
- 2023-12-21
- Accepted Time:
- 2023-12-22 17:01:07
- Original Submission Date:
- 2023-12-14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1762303 | Avita Medical Inc. | RCEL | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1216486 | Curnock Jeremy Cook | C/O Avita Medical 28159 Avenue Stanford Suite 220 Valencia CA 91355 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common | Disposition | 2023-12-21 | 2,500 | $12.49 | 20,614 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold to cover UK tax obligation incurred by the Reporting Person upon the vesting of RSUs
- The original Form 4, filed on December 14, 2023, is being amended by this Form 4 to correct an administrative error, which misreported a sale of common stock to cover taxes for vesting of RSUs on the wrong date. The sale of the stock was reported on December 13, 2023, however, the actual sale occured on December 21, 2023. This Form 4 reflects the correction to the date, price and number of shares sold in the transaction.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $12.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4.
- Includes unvested RSUs